TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
GlaxoSmithKline AS
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
891,471
|
901,790
|
802,039 |
Financial expenses |
875
|
320
|
2,464 |
Earnings before taxes |
27,432
|
29,547
|
29,884 |
Total assets |
288,260
|
287,694
|
350,183 |
Current assets |
207,637
|
206,483
|
268,412 |
Current liabilities |
173,469
|
164,757
|
231,442 |
Equity capital |
114,791
|
122,936
|
118,741 |
- share capital |
938
|
1,004
|
974 |
Employees (average) | 56 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
39.8%
|
42.7%
|
33.9% |
Turnover per employee | 14,322 | ||
Profit as a percentage of turnover |
3.1%
|
3.3%
|
3.7% |
Return on assets (ROA) |
9.8%
|
10.4%
|
9.2% |
Current ratio |
119.7%
|
125.3%
|
116.0% |
Return on equity (ROE) |
23.9%
|
24.0%
|
25.2% |
Change turnover |
49,429
|
74,900
|
-95,802 |
Change turnover % |
6%
|
9%
|
-11% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.